Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
Research ArticleResearch

Increasing likelihood of prescribing recommended lipid management

Primary care providers’ participation in cardiology continuing medical education

Diana C. Sanchez-Ramirez, Alexander G. Singer, Leanne Kosowan, Alan Katz and Christine Polimeni
Canadian Family Physician January 2022, 68 (1) 39-46; DOI: https://doi.org/10.46747/cfp.680139
Diana C. Sanchez-Ramirez
Assistant Professor in the College of Rehabilitation Sciences in the Rady Faculty of Health Sciences at the University of Manitoba in Winnipeg.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: diana.sanchez-ramirez@umanitoba.ca
Alexander G. Singer
Associate Professor in the Department of Family Medicine in the Rady Faculty of Health Sciences at the University of Manitoba.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leanne Kosowan
Research Coordinator and Data Analyst in the Department of Family Medicine in the Rady Faculty of Health Sciences at the University of Manitoba.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan Katz
Professor in the Department of Family Medicine in the Rady Faculty of Health Sciences at the University of Manitoba.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christine Polimeni
Vice Dean of the Office of Continuing Competency and Assessment in the Rady Faculty of Health Sciences at the University of Manitoba.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

Abstract

Objective To explore whether participation in a series of cardiology continuing medical education (CME) activities affects primary care providers’ (PCPs’) lipid management for their patients.

Design This retrospective cohort study used a database of participation in cardiology CME activities (2011 to 2017) linked to electronic medical records. Statistical analyses were completed using logistic regression with generalized estimating equations.

Setting Manitoba.

Participants Patients receiving care from 225 PCPs participating in the Manitoba Primary Care Research Network.

Main outcome measures Recommended lipid management was defined as prescription of statins (yes or no) among patients diagnosed with cardiovascular disease (CVD), patients diagnosed with diabetes mellitus (DM; 40 years or older), and patients diagnosed with chronic kidney disease (CKD; 50 years and older) in 2017. Treatment was identified using the ATC (Anatomical Therapeutic Chemical) system (ATC code C10AA or C10B).

Results After adjusting for relevant confounders, the odds of prescribing statins to patients with CVD, DM, or CKD among PCPs who did not participate in the cardiology CME activities were 50%, 55%, and 67% lower, respectively, than among PCPs who participated in 2 or more activities. The odds of prescribing statins to patients with CVD and DM among PCPs who participated in only 1 cardiology CME activity were also 67% and 63% lower, respectively, than among PCPs who participated in 2 or more activities.

Conclusion Results suggested that PCPs who participated in 2 or more cardiology CME activities were more likely to prescribe recommended lipid management (statins) for adults with CVD, DM, or CKD.

Cardiovascular disease (CVD) is the primary cause of death globally, accounting for 31% (17.9 million persons) of all deaths in 2016.1 In 2015, heart and cerebrovascular diseases were the second and third leading causes of deaths in Canada.2 Researchers have demonstrated a reduction of CVD mortality in patients with high-risk conditions who are treated with statin medication.3-5 Consequently, clinical practice guidelines recommend statin (HMG-CoA [β-hydroxy-β-methylglutaryl coenzyme A] reductase inhibitor) medications for patients diagnosed with CVD, patients 40 years or older who have diabetes mellitus (DM; type 1 or type 2), and patients 50 years or older diagnosed with chronic kidney disease (CKD).6-9 Evidence-based clinical practice guidelines are commonly incorporated into continuing medical education (CME) activities.

Continuing medical education aims to enhance health care professionals’ knowledge, teach new skills, and build on existing skills to provide the best possible care, improve patient outcomes, and protect patient safety.10,11 Summative assessments (ie, self-reported questionnaires, knowledge tests, and commitment-to-change exercises) used to measure CME effectiveness demonstrate knowledge gains.11 However, the lack of metrics and objective data has hindered measurement of clinical performance and patient outcomes in relation to CME activities. Rayburn and Davis12 suggest that patient health records and administrative data contained in databases could be used to overcome this knowledge gap. To the best of our knowledge, however, few have attempted to use these sources of data to assess the effectiveness of CME.13 Therefore, this study used electronic medical records (EMRs) to explore associations between recommended statin prescribing to patients with CVD, DM, or CKD and primary care providers’ (PCPs’) participation in a series of cardiology CME activities.

METHODS

This retrospective study, approved by the health research ethics board of the University of Manitoba in Winnipeg, linked information about PCPs’ participation in cardiology CME activities (2011 to 2017) to patients’ EMRs. All PCPs in the study participated in the Manitoba Primary Care Research Network (MaPCReN) in 2017. A unique provider identification number was used to link participation in CME activities with de-identified records from EMRs. The MaPCReN database contains information extracted from 48 primary care clinics and more than 255 PCPs (family physicians and nurse practitioners), representing more than 288 000 patients in Manitoba. The Manitoba Primary Care Research Network is part of the Canadian Primary Care Sentinel Surveillance Network database. The Canadian Primary Care Sentinel Surveillance Network is a pan-Canadian network that extracts de-identified EMR data from consenting PCPs.

It has developed and validated methods for capturing information about patients with several chronic diseases, including CVD, DM, and CKD.

Study setting

Manitoba is 1 of the 3 Prairie Provinces of Canada, with a population of 1 356 961 (57% in Winnipeg) in 2017.14 Canada maintains a universal, publicly funded health care system that provides Manitobans access to health care services. The provincial pharmacare program covers the cost of some prescribed medications for Manitoba residents who spend a large amount of their income on medications, once the income-based deductible is paid. In 2017, approximately 1648 PCPs (178 [11%] nurse practitioners and 1470 [89%] family physicians) were registered in Manitoba.

Cardiology CME

The Office of Continuing Competency and Assessment in the Rady Faculty of Health Sciences at the University of Manitoba hosted a yearly CME activity in the form of “Cardiology Day” from 2011 to 2017. We offered a series of 20- to 30-minute lectures followed by about 10 minutes of questions and answers that fulfilled the interactive component of educational standards for accredited CME. (Accredited programs must dedicate at least 25% of instruction time to interactive learning.) These 1-day (8:30 am to 2:45 pm) accredited programs were planned by a committee composed of family physicians and specialists in cardiology, who defined the most suitable themes and speakers based on their experience, informed by literature and local needs assessment surveys. The cardiology CME activities aimed to provide an overview of advances made in diagnostics, prevention, and medical and surgical treatment of CVD. The target audience comprised family physicians, medical and surgical specialists, nurse practitioners, nurses, physician assistants, and other allied health professionals who wished to update their general knowledge of cardiology. Apart from 2016, a session on recommended lipid management was incorporated into each cardiology CME program, reflecting its important role in decreasing CVD mortality.

Data

Data from PCPs and patients were extracted from the MaPCReN repository (2017, quarter 2) for the year 2017. Patients’ EMRs were reviewed for diagnoses of CVD, CKD, or DM (ie, ICD-9 diagnostic codes):

  • the CVD ICD-9 Clinical Modification (ICD-9-CM) code (429.2), the ICD-9 codes for atrial fibrillation or flutter (427.3, 427.31, 427.32), or the ICD-9 code for valvular disease (394.x, 395.x, 396.x, 424.0 or V43.3);

  • the CKD ICD-9 code (585.9); and

  • the DM (types 1 and 2) ICD-9-CM code (250), Anatomical Therapeutic Chemical (ATC) codes for diabetes medicine (A10), or hemoglobin A1c level of 7 or more. Patients were excluded if they had a diabetes medication and an ICD-9-CM code for gestational diabetes (648.8), chemical-induced (secular) diabetes (249), neonatal diabetes (775.1), polycystic ovary syndrome (256.4), or nitric oxide synthesis hyperglycemia (790.29).15,16

How many times PCPs attended cardiology CME activities from 2011 to 2017 was linked to PCPs’ EMRs from MaPCReN in 2017 and grouped in 3 categories according to participation in 2 or more activities, 1 activity, or no activities. The 2016 cardiac CME activity did not include a session on lipid management and therefore was excluded from analyses.

Outcome measures

Among patients diagnosed with CVD, DM (≥ 40 years), and CKD (≥ 50 years) in 2017 were identified using the ATC system (ATC code C10AA or C10B).

Providers’ and patients’ characteristics

Characteristics of PCPs and patients listed in MaPCReN and included in the study are age (in years) and sex (female vs male). Additional provider characteristics included type of provider (family physician vs nurse practitioner), location of practice (rural vs urban), type of funding (salary vs fee-for-service), large practice (837 or more patients; 837 is the median practice size of the cohort), and graduate of a Canadian medical school (no vs yes). Prescribing data within the EMR can be linked to individual patients and providers by unique identification numbers.

Analysis

We used the conceptual framework of Moore et al,17 which assesses the learner’s change in performance after participation in a CME activity, to explore the effect of educational activities on clinical practice. This theoretical model is based on Kirkpatrick and Kirkpatrick’s framework,18 a benchmark for assessing desired learning outcomes, which also incorporates theories specific to medical education.

Descriptive statistics were used to present the characteristics of PCPs in relation to their participation in cardiology CME activities. Percentages were used for categorical variables and means and SDs for continuous variables.

Crude and adjusted logistic regression models with generalized estimating equations clustered at the PCP level were used to analyze statin prescription among patients diagnosed with CVD, patients 40 years or older with DM, or patients 50 years or older with CKD in 2017 in relation to PCPs’ participation in cardiology CME activities. The category of participation in 2 or more cardiology CME activities was used as a reference.

Statistical significance was accepted at P values below .05. All analyses were performed using SPSS software, version 25.0.

RESULTS

Two hundred twenty-five PCPs had in their practices patients with CVD, patients 40 years or older with DM, or patients 50 years or older with CKD in 2017. The mean (SD) age of PCPs was 47.6 (10.0) years, 40% were male, and 84% were family physicians. Four percent of PCPs participated in 2 or more cardiology CME activities at the University of Manitoba, 16% participated in 1 activity, and 80% participated in none. There were significant differences in sex (P = .01), type of provider (P < .01), and practice size (P = .04) in relation with participation in cardiology CME activities (Table 1). However, no other characteristics of PCPs, nor proportions of patients with CVD, DM, and CKD in their practices were statistically different across groups (Table 1). The PCPs who participated in 2 or more cardiology CME events prescribed statins to a larger percentage of their patients with CVD, DM, and CKD in 2017 than PCPs who participated in 1 event or no events (Table 2).

View this table:
  • View inline
  • View popup
Table 1.

Primary care providers by participation in cardiology CME activities from 2011 to 2017: Four percent of PCPs participated in ≥ 2 activities, 16% participated in 1 activity, and 80% participated in none.

View this table:
  • View inline
  • View popup
Table 2.

Primary care providers’ participation in cardiology CME activities from 2011 to 2017 and prescription of statins in 2017: N = 225 PCPs.

Statins for patients with CVD

Adjusted odds ratios (aORs) of prescribing statins to patients with CVD among PCPs who participated in 1 (aOR = 0.31, 95% CI 0.19 to 0.50, P < .001) or no (aOR = 0.50, 95% CI 0.33 to 0.77, P = .002) cardiology CME activities were lower compared with PCPs who participated in 2 or more cardiology CME activities. The fully adjusted model also identified lower odds of prescribing statins to patients with CVD associated with female patients (aOR = 0.58, 95% CI 0.50 to 0.69, P < .001), younger patients (aOR = 1.006, 95% CI 1.002 to 1.011, P = .01), salaried providers (aOR = 0.71, 95% CI 0.56 to 0.89, P = .003), and providers in rural practices (aOR = 0.81, 95% CI 0.68 to 0.97, P = .02) (Table 3).

View this table:
  • View inline
  • View popup
Table 3.

Primary care providers’ prescription of statins to patients in 2017 according to recommended clinical practice: A) Crude model, B) adjusted model. Bolded values indicate statistical significance.

Statins for patients with DM

Adjusted odds of prescribing statins to patients 40 years or older with DM among PCPs who participated in 1 (aOR = 0.37, 95% CI 0.29 to 0.47, P < .001) or no (aOR = 0.45, 95% CI 0.36 to 0.55, P < .001) cardiology CME activities were lower than among PCPs who participated in 2 or more cardiology CME activities. The fully adjusted model also showed that lower odds of prescribing statins in this group of patients were associated with female patients (aOR = 0.76, 95% CI 0.71 to 0.82, P < .001), younger patients (aOR = 1.008, 95% CI 1.006 to 1.011, P < .001), salaried providers (aOR = 0.75, 95% CI 0.68 to 0.84, P < .001), providers in rural practices (aOR = 0.69, 95% CI 0.63 to 0.75, P < .001), and providers trained in Canada (aOR = 0.77, 95% CI 0.70 to 0.85, P < .001) (Table 3).

Statins for patients with CKD

Adjusted odds of prescribing statins to patients 50 years or older with CKD among PCPs who did not participate in cardiology CME events were lower (aOR = 0.33, 95% CI 0.15 to 0.75, P = .01) compared with PCPs who participated in 2 or more events. No other variables were significantly associated with prescribing statins to this group of patients (Table 3).

DISCUSSION

We found that PCPs who participated in 2 or more cardiology CME activities were more likely to provide recommended statin treatment to adults with CVD, DM, or CKD. This suggests that participation in CME activities improves clinical practice (Moore et al’s level 5 performance17). Evidence shows that CME activities increase physicians’ knowledge and competence.11 However, studies that assess the effect of CME in clinical practice and patient health outcomes are scarce. To the best of our knowledge, this is the first study to use medical records to evaluate the association between participation in recurrent CME activities and recommended clinical practice. These findings support targeted medical education and recurrent CME programs for health care providers.

Besides PCPs’ participation in cardiology CME activities, results also showed that some characteristics of patients and providers were associated with prescription of recommended statin treatment to adults with CVD or DM. Female and younger patients had lower odds of receiving prescriptions for statins, which aligns with previous data showing that men 60 years and older reported the highest percentage of lipid-lowering medication intake in the United States.19,20 These findings could be influenced by previous evidence that associated prescribing statin therapy with larger reductions in mortality rates in men than in women21 and that showed positive effects of statin therapy among elderly patients.22 Cardiovascular risk increases with age; thus the prospective risk reduction is greater in older patients, meaning this finding of our study supports the practice pattern expected if clinical decision making is patient centred.

Salaried providers, providers in urban practices, and Canada-trained providers had lower odds of prescribing statins. The impact of physician payment method on quality of care is controversial. Previous studies suggest that salaried PCPs prescribe less often23,24; however, it is possible that less prescribing might better reflect the needs of patients because salaried physicians are able to expend more time analyzing each case. Several health care challenges have been documented in rural areas, usually expressed in terms of access, use, cost, and geographic distribution of providers and services.25 These challenges (together with absence of communities of practice,26 barriers to accessing CME, and unique CME needs27) might have affected the practice of evidence-based care in rural settings. It is possible that foreign-trained PCPs felt more pressure to comply with local standards of care28 and were therefore more inclined to incorporate Canadian guidelines into their clinical practice.

Previous research found that, despite strong evidence that statin treatment is effective in primary prevention,29 PCPs still underprescribe recommended statin treatment for people at high risk of CVD.15,30-32 In addition to the variable captured in this study, other factors could increase reluctance to adopt recommended care (clinical guidelines), such as disagreement with the underlying evidence, individual patient factors (eg, adverse effects, nonadherence), lack of knowledge of guidelines, and unclear or ambiguous recommendations.27

Limitations and strengths

Some limitations of this study should be considered when interpreting the results. First, we were unable to measure whether PCPs received similar CME from other sources outside our institution. However, this research provides an overview of the effect of a recurrent (annual) and wellattended (about 120 to 180 health care providers yearly) CME activity led by the University of Manitoba, which is one of the main CME providers in the province. Second, although data included in this study represent a large sample of PCPs and patients in Manitoba, the MaPCReN database includes only consenting PCPs in Manitoba (approximately 16% of Manitoba providers). Third, it is possible that prescriptions that did not align with the guidelines were influenced by PCPs’ disagreement or personal interpretations, which are impossible to account for in the EMR data. Fourth, it was impossible to capture PCPs’ interest in and knowledge of the recommendations before the CME activity. The PCPs who attended a cardiology-focused CME activity could have had previous interest in CVD and could have been more likely to be aware of relevant recommendations and to prescribe statins accordingly. In this scenario, CME providers should explore strategies to reach PCPs who are not participating in current CME events. Fifth, our study used only structured data files available within the EMR and not clinic encounter notes, which might have provided more detail about treatment decisions (eg, clinical presentation, discussion with patients). Finally, this study was based on EMRs that could have had incomplete data.33,34 Nevertheless, using clinical data from EMRs has been shown to be valid for identifying diagnoses.35,36

Strengths of this study include the use of good-quality EMR data from the MaPCReN database and longitudinal information about participation in a recurrent CME activity, together with the ability to link the 2 data sets. Further, this is one of the few studies objectively exploring the potential association between PCPs’ participation in CME and clinical practice.

Conclusion

This study found that PCPs who participated in 2 or more cardiology CME activities had higher odds of providing recommended statin treatment to adults with CVD, DM, or CKD. While several factors might influence clinical decision making, our results still suggest that participation in CME activities has a positive effect on clinical practice. This valuable information can serve to support targeted medical education and recurrent CME activities for health care providers.

Notes

Editor’s key points

  • ▸ Primary care providers who participated in 2 or more cardiology continuing medical education (CME) activities were more likely to prescribe recommended lipid management (statins) for adults with cardiovascular disease, diabetes mellitus, or chronic kidney disease.

  • ▸ Results also showed that some characteristics of patients and providers were associated with prescription of recommended statin treatment to adults with cardiovascular disease or diabetes mellitus. Female and younger patients had lower odds of receiving prescriptions for statins. Salaried providers, providers in urban practices, and Canada-trained providers had lower odds of prescribing statins.

  • ▸ To the best of our knowledge, this is the first study to use medical records to evaluate the association between participation in recurrent CME activities and recommended clinical practice. These findings support targeted medical education and recurrent CME programs for health care providers.

Points de repère du rédacteur

  • ▸ Les professionnels des soins primaires qui avaient participé à 2 activités ou plus de formation médicale continue (FMC) en cardiologie étaient plus susceptibles de prescrire le contrôle des lipides (statines) recommandé aux adultes atteints de maladies cardiovasculaires, de diabète sucré ou de néphropathie chronique.

  • ▸ Les résultats ont aussi démontré que certaines caractéristiques des patients et des professionnels étaient associées à la prescription de statines recommandée aux adultes atteints de maladies cardiovasculaires ou de diabète sucré. Il était moins probable que les femmes et les patients plus jeunes reçoivent une prescription de statines. Les professionnels salariés, les professionnels dans les pratiques urbaines et les professionnels formés au Canada étaient moins enclins à prescrire des statines.

  • ▸ Au meilleur de nos connaissances, il s’agit de la première étude dans laquelle les dossiers médicaux ont servi à évaluer l’association entre la participation à des activités de FMC récurrentes et la pratique clinique recommandée. Ces constatations étayent l’importance d’une formation médicale ciblée et de programmes de FMC récurrents à l’intention des professionnels de la santé.

Footnotes

  • Contributors

    Dr Diana C. Sanchez-Ramirez contributed to the concept, design, and data analysis of the study. Leanne Kosowan assisted with the data gathering. All authors contributed to the interpretation of the data and the preparation of the manuscript.

  • Competing interests

    Dr Alexander G. Singer received a research grant administered by the Canadian Institute for Military and Veteran Health Research funded by IBM and Calian not related to the findings of this study.

  • This article has been peer reviewed.

    Cet article a fait l’objet d’une révision par des pairs.

  • Copyright © 2022 the College of Family Physicians of Canada

References

  1. 1.↵
    Cardiovascular diseases (CVD). Geneva, Switz: World Health Organization; 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds). Accessed 2021 Nov 23.
  2. 2.↵
    Deaths and causes of death, 2015. Report 84-437-X. Ottawa, ON: Statistics Canada; 2018.
  3. 3.↵
    1. Collins R,
    2. Armitage J,
    3. Parish S,
    4. Sleigh P,
    5. Peto R; Heart Protection Study Collaborative Group
    . MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003;361(9374):2005-16.
    OpenUrlCrossRefPubMed
  4. 4.
    1. Colhoun HM,
    2. Betteridge DJ,
    3. Durrington PN,
    4. Hitman GA,
    5. Neil HA,
    6. Livingstone SJ, et al.
    Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004;364(9435):685-96.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Palmer SC,
    2. Craig JC,
    3. Navaneethan SD,
    4. Tonelli M,
    5. Pellegrini F,
    6. Strippoli GF
    . Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med 2012;157(4):263-75.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Anderson TJ,
    2. Gregoire J,
    3. Pearson GJ,
    4. Barry AR,
    5. Couture P,
    6. Dawes M, et al.
    2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol 2016;32(11):1263-82.
    OpenUrlCrossRefPubMed
  7. 7.
    1. Diabetes Canada Clinical Practice Guidelines Expert Committee
    . Diabetes Canada 2018 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2018;42(Suppl 1):S1-325.
    OpenUrl
  8. 8.
    1. Genest J,
    2. McPherson R,
    3. Frohlich J,
    4. Anderson T,
    5. Campbell N,
    6. Carpentier A, et al.
    2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult—2009 recommendations. Can J Cardiol 2009;25(10):567-79.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Diabetes Canada Clinical Practice Guidelines Expert Committee
    . Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008;32(Suppl):S1-201.
    OpenUrl
  10. 10.↵
    1. Institute of Medicine (US) Committee on Planning a Continuing Health Professional Education Institute
    . Redesigning continuing education in the health professions. Washington, DC: The National Academies Press; 2010.
  11. 11.↵
    1. Wallace S,
    2. May SA
    . Assessing and enhancing quality through outcomes-based continuing professional development (CPD): a review of current practice. Vet Rec 2016;179(20):515-20.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Rayburn W,
    2. Davis DA
    . Continuing professional development in medicine and health care: better education, better patient outcomes. Alphen aan den Rijn, The Netherlands: Wolters Kluwer; 2018.
  13. 13.↵
    1. Price DW,
    2. Xu S,
    3. McClure D
    . Effect of CME on primary care and OB/GYN treatment of breast masses. J Contin Educ Health Prof 2005;25(4):240-7.
    OpenUrlPubMed
  14. 14.↵
    Manitoba. Population report June 1, 2017. Winnipeg, MB: Manitoba Health, Healthy Living and Seniors; 2017.
  15. 15.↵
    1. Sanchez-Ramirez DC,
    2. Singer A,
    3. Kosowan L,
    4. Polimeni C
    . Exploring clinical care among adults with diabetes mellitus: alignment with recommended statin and sulfonylureas treatment. Can J Diabetes 2019;43(7):498-503.
    OpenUrl
  16. 16.↵
    1. Williamson T,
    2. Green ME,
    3. Birtwhistle R,
    4. Khan S,
    5. Garies S,
    6. Wong ST, et al.
    Validating the 8 CPCSSN case definitions for chronic disease surveillance in a primary care database of electronic health records. Ann Fam Med 2014;12(4):367-72.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Moore DE Jr,
    2. Green JS,
    3. Gallis HA
    . Achieving desired results and improved outcomes: integrating planning and assessment throughout learning activities. J Contin Educ Health Prof 2009;29(1):1-15.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Kirkpatrick D,
    2. Kirkpatrick J
    . Evaluating training programs: the four levels. San Francisco, CA: Berrett-Koehler Publishers Inc; 2006.
  19. 19.↵
    1. Carroll MD,
    2. Mussolino ME,
    3. Wolz M,
    4. Srinivas PR
    . Trends in apolipoprotein B, non– high-density lipoprotein, and low-density lipoprotein for adults 60 years and older by use of lipid-lowering medications: United States, 2005 to 2006 through 2013 to 2014. Circulation 2018;138(2):208-10.
    OpenUrlFREE Full Text
  20. 20.↵
    1. Centers for Disease Control and Prevention
    . Percentage of adults aged ≥ 20 years told their cholesterol was high who were taking lipid-lowering medication, by sex and age group—National Health and Nutrition Examination Survey, 2005-2006 to 2015-2016. MMWR Morb Mortal Wkly Rep 2018;67(27):771.
    OpenUrl
  21. 21.↵
    1. Karp I,
    2. Chen SF,
    3. Pilote L
    . Sex differences in the effectiveness of statins after myocardial infarction. CMAJ 2007;176(3):333-8.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Shepherd J,
    2. Blauw GJ,
    3. Murphy MB,
    4. Bollen EL,
    5. Buckley BM,
    6. Cobbe SM, et al.
    Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 2002;360(9346):1623-30.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Rudmik L,
    2. Wranik D,
    3. Rudisill-Michaelsen C
    . Physician payment methods: a focus on quality and cost control. J Otolaryngol Head Neck Surg 2014;43(1):34.
    OpenUrl
  24. 24.↵
    1. Gosden T,
    2. Sibbald B,
    3. Williams J,
    4. Petchey R,
    5. Leese B
    . Paying doctors by salary: a controlled study of general practitioner behaviour in England. Health Policy 2003;64(3):415-23.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Hartley D
    . Rural health disparities, population health, and rural culture. Am J Public Health 2004;94(10):1675-8.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Chipp C,
    2. Dewane S,
    3. Brems C,
    4. Johnson ME,
    5. Warner TD,
    6. Roberts LW
    . “If only someone had told me …”: lessons from rural providers. J Rural Health 2011;27(1):122-30.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Lugtenberg M,
    2. Zegers-van Schaick JM,
    3. Westert GP,
    4. Burgers JS
    . Why don’t physicians adhere to guideline recommendations in practice? An analysis of barriers among Dutch general practitioners. Implement Sci 2009;4:54.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Chen PGC,
    2. Nunez-Smith M,
    3. Bernheim SM,
    4. Berg D,
    5. Gozu A,
    6. Curry LA
    . Professional experiences of international medical graduates practicing primary care in the United States. J Gen Intern Med 2010;25(9):947-53.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Public Health Agency of Canada
    . Diabetes in Canada: facts and figures from a public health perspective. Ottawa, ON: Government of Canada; 2011.
  30. 30.↵
    1. Van Staa TP,
    2. Smeeth L,
    3. Ng ES,
    4. Goldacre B,
    5. Gulliford M
    . The efficiency of cardiovascular risk assessment: do the right patients get statin treatment? Heart 2013;99(21):1597-602.
    OpenUrlAbstract/FREE Full Text
  31. 31.
    1. Ko DT,
    2. Mamdani M,
    3. Alter DA
    . Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox. JAMA 2004;291(15):1864-70.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Hennessy DA,
    2. Tanuseputro P,
    3. Tuna M,
    4. Bennett C,
    5. Perez R,
    6. Shields M, et al.
    Population health impact of statin treatment in Canada. Health Rep 2016;27(1):20-8.
    OpenUrlPubMed
  33. 33.↵
    1. Singer A,
    2. Yakubovich S,
    3. Kroeker AL,
    4. Dufault B,
    5. Duarte R,
    6. Katz A
    . Data quality of electronic medical records in Manitoba: do problem lists accurately reflect chronic disease billing diagnoses? J Am Med Inform Assoc 2016;23(6):1107-12.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Singer A,
    2. Kroeker AL,
    3. Yakubovich S,
    4. Duarte R,
    5. Dufault B,
    6. Katz A
    . Data quality in electronic medical records in Manitoba. Do problem lists reflect chronic disease as defined by prescriptions? Can Fam Physician 2017;63:382-9.
    OpenUrlAbstract/FREE Full Text
  35. 35.↵
    1. Kern DM,
    2. Davis J,
    3. Williams SA,
    4. Tunceli O,
    5. Wu B,
    6. Hollis S, et al.
    Validation of an administrative claims-based diagnostic code for pneumonia in a US-based commercially insured COPD population. Int J Chron Obstruct Pulmon Dis 2015;10:1417-25.
    OpenUrl
  36. 36.↵
    1. Katz A,
    2. Halas G,
    3. Dillon M,
    4. Sloshower J
    . Describing the content of primary care: limitations of Canadian billing data. BMC Fam Pract 2012;13:7.
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

Canadian Family Physician: 68 (1)
Canadian Family Physician
Vol. 68, Issue 1
1 Jan 2022
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Increasing likelihood of prescribing recommended lipid management
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Increasing likelihood of prescribing recommended lipid management
Diana C. Sanchez-Ramirez, Alexander G. Singer, Leanne Kosowan, Alan Katz, Christine Polimeni
Canadian Family Physician Jan 2022, 68 (1) 39-46; DOI: 10.46747/cfp.680139

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Increasing likelihood of prescribing recommended lipid management
Diana C. Sanchez-Ramirez, Alexander G. Singer, Leanne Kosowan, Alan Katz, Christine Polimeni
Canadian Family Physician Jan 2022, 68 (1) 39-46; DOI: 10.46747/cfp.680139
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • METHODS
    • RESULTS
    • DISCUSSION
    • Notes
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Systematic assessment of opioid advertisements in general medical journals
  • Timely access to primary care in New Brunswick
  • Older persons living with dementia and their use of acute care services over 2 years in Alberta
Show more Research

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • RSS Feeds

Copyright © 2023 by The College of Family Physicians of Canada

Powered by HighWire